Spero Therapeutics announced that Chief Operating Officer (COO) Timothy Keutzer will retire from the company at the end of the year. Following his retirement, Mr. Keutzer is expected to provide consulting services to support the leadership transition.
Key Details
- Retiring Officer: Timothy Keutzer, Chief Operating Officer.
- Effective Date: The retirement is effective as of December 31, 2026.
- Transition Plan: Mr. Keutzer is expected to enter into a consulting agreement to provide advisory services until approximately February 28, 2027.